PSP Research »

Erasca shares owned by PSP Research

Quarter-by-quarter ownership of Erasca (ERAS) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Erasca

Tip: Access up to 7 years of quarterly data

All positions including Erasca held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Erasca by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $280k 17k 16.18

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Erasca

Frazier Life Sciences Management
VR Adviser
T. Rowe Price Investment Management
BlackRock
Suvretta Capital Management
Paradigm Biocapital Advisors
Logos Global Management
Vanguard Group
Arch Venture Corp
Vivo Capital
Siren
State Street Corporation
5AM Venture Management
Geode Capital Management
Affinity Asset Advisors

View all funds holding Erasca